nach oben

Erschienen in:

01.11.2023 | Clinical study

COVID-19 vaccination: large impact on reporting of ADRs not related to COVID-19 vaccines in France

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

COVID-19 vaccination had a significant impact on the reporting of adverse drug reactions (ADRs) not related to COVID-19 vaccines in France, with an average decrease in monthly reporting of approximately 35%. …

de Germay S, et al. Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France. Drug Safety : 5 Nov 2023. Available from: URL: https://doi.org/10.1007/s40264-023-01359-4

Titel: COVID-19 vaccination: large impact on reporting of ADRs not related to COVID-19 vaccines in France
Publikationsdatum: 01.11.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-49358-x

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

COVID-19 vaccination: large impact on reporting of ADRs not related to COVID-19 vaccines in France

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Ibrutinib/methotrexate

Multiple drugs

Magnesium-oxide/magnesium-sulfate

Aflibercept

Paracetamol

Carboplatin/paclitaxel